Literature DB >> 2536830

Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains.

J W Hartley1, T N Fredrickson, R A Yetter, M Makino, H C Morse.   

Abstract

C57BL mice (Fv-1b) develop a severe immunodeficiency disease following inoculation as adults with LP-BM5 murine leukemia virus (MuLV), a derivative of Duplan-Laterjet virus which contains B-tropic ecotropic and mink cell focus-inducing MuLVs and a putative defective genome which may be the proximal cause of disease. The stages of development of this disease were defined for C57BL mice on the basis of lymphadenopathy and splenomegaly; histopathological changes consistent with B-cell activation; and alterations in expression of cell surface antigens affected by proliferation of T cells, B cells, and macrophages. By using this disease profile as a standard, the response of adult mice of various inbred strains and selected F1 hybrids was compared. We show that although the strains which are highly sensitive are of the Fv-1b genotype (i.e., permissive for B-tropic MuLVs), certain Fv-1b strains, e.g., BALB/c and A/J, are resistant to murine acquired immunodeficiency syndrome, whereas certain Fv-1n strains (permissive for N-tropic MuLVs but restrictive for B-tropic MuLVs), notably P/N, BDP, and AKR, show moderate sensitivity and (C57BL/6 x CBA/N)F1 mice (Fv-1n/b and thus dually restrictive) are of relatively high susceptibility. The results of virus recovery tests suggest that apparently anomalous sensitivity, based on predicted Fv-1 restriction, may reflect MuLV induction and/or mutation to provide a helper virus for which the host is permissive.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536830      PMCID: PMC247818     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice.

Authors:  W F Davidson; F J Dumont; H G Bedigian; B J Fowlkes; H C Morse
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

2.  Reticulum cell neoplasms induced in C57BL/6 mice by cultured virus grown in stromal hematopoietic cell lines.

Authors:  M Haas; A Meshorer
Journal:  J Natl Cancer Inst       Date:  1979-08       Impact factor: 13.506

3.  Induction of B-tropic and N-tropic murine leukemia virus from B10.BR/SgLi mouse embryo cell lines by 5-iodo-2'-deoxyuridine.

Authors:  B Moll; J W Hartley; W P Rowe
Journal:  J Natl Cancer Inst       Date:  1979-07       Impact factor: 13.506

4.  Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV).

Authors:  P K Pattengale; C R Taylor; P Twomey; S Hill; J Jonasson; T Beardsley; M Haas
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

5.  Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses.

Authors:  L DesGroseillers; P Jolicoeur
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

6.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.

Authors:  D E Mosier; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

7.  Murine hematopoietic cells with pre-B or pre-B/myeloid characteristics are generated by in vitro transformation with retroviruses containing fes, ras, abl, and src oncogenes.

Authors:  K L Holmes; J H Pierce; W F Davidson; H C Morse
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

8.  Genes affecting mink cell focus-inducing (MCF) murine leukemia virus infection and spontaneous lymphoma in AKR F1 hybrids.

Authors:  W P Rowe; J W Hartley
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

9.  A mouse gene on chromosome 5 that restricts infectivity of mink cell focus-forming recombinant murine leukemia viruses.

Authors:  J W Hartley; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

10.  Genetic study of lymphoma induction by AKR mink cell focus-inducing virus in AKR x NFS crosses.

Authors:  M W Cloyd; J W Hartley; W P Rowe
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  77 in total

1.  LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.

Authors:  E Koustova; Y Sei; L Fossom; M L Wei; P N Usherwood; N B Keele; M A Rogawski; A S Basile
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.

Authors:  Christine L Clouser; Colleen M Holtz; Mary Mullett; Daune L Crankshaw; Jacquie E Briggs; M Gerard O'Sullivan; Steven E Patterson; Louis M Mansky
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

3.  Effects of non-MHC loci on resistance to retrovirus-induced immunodeficiency in mice.

Authors:  M Makino; W F Davidson; T N Fredrickson; J W Hartley; H C Morse
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice.

Authors:  S K Chattopadhyay; D N Sengupta; T N Fredrickson; H C Morse; J W Hartley
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Molecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual.

Authors:  R S Daniels; M H Smith; A G Fisher
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

6.  Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency.

Authors:  Kathy A Green; W James Cook; William R Green
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

7.  Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs.

Authors:  C Simard; M Huang; P Jolicoeur
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Inhibition of murine AIDS (MAIDS), development by the transplantation of bone marrow cells carrying the Fv-4 resistance gene to MAIDS virus-infected mice.

Authors:  Y Nakagawa; K Kakimi; W Ling; Y Kubo; K Higo; T Masuda; K Kuribayashi; M Iwashiro; Y Komatz; T Hirama
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.

Authors:  K A Green; K M Crassi; J D Laman; A Schoneveld; R R Strawbridge; T M Foy; R J Noelle; W R Green
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection.

Authors:  B B Mittleman; H C Morse; S M Payne; G M Shearer; E Mozes
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.